duns,field,value
751908968,Physical Address,"4 CARIBBEAN DRIVE, SCORESBY, 3179, VIC, Australia"
751908968,Telephone Number,03 95471888
751908968,ACN,106340667
751908968,Primary SIC,"2834 - Pharmaceutical Preparations Summary > Medical Developments International Limited (MVP) is an Australian company delivering emergency medical solutions, including pain relief and respiratory products, and is dedicated to improving patient outcomes. The Company manufactures Penthrox, a non-opioid trauma & emergency pain relief product. It is approved in Australia for pain relief in settings such as hospitals, ambulance services and short procedures, in accordance with the approved Product Information. Key Personnel > No key personnel were found for the selected company. Key Information > Revenue ($000s) $33,149 Sourced directly from company Number of Employees 68(G) Fiscal Year End June Key Financials > 2024 AUD	2023 AUD	2022 AUD	2021 AUD	2020 AUD	2019 AUD	2018 AUD	2017 AUD	2016 AUD	2015 AUD Revenue from continuing operations ($000s)	$33,149	$32,337	$22,369	$25,272	$22,535	$20,876	$17,461	$18,347	$15,471	$11,608 Growth	2.51%	44.56%	(11.49%)	12.15%	7.95%	19.56%	(4.83%)	18.59%	33.28%	- Gross profit ($000s)	$24,366	$22,212	$15,634	$19,099	$14,992	$14,184	$12,364	$12,583	$11,211	$8,054 Growth	9.70%	42.07%	(18.14%)	27.39%	5.70%	14.72%	(1.74%)	12.24%	39.20%	- Other non-current liabilities ($000s)	$1,637	$1,899	$21,607	$21,907	$30,000	$31,425	$13,048	$14,416	$12,951	$934 EBITDA ($000s)	($13,071)	$2,425	($12,279)	($11,108)	$3,032	$3,888	$2,223	$3,804	$3,421	$2,257 Growth	-	-	-	-	(22.02%)	74.90%	(41.56%)	11.20%	51.57%	- EBITDA margin	(148.47)%	(53.25)%	(73.25)%	(73.62)%	(9.59)%	(3.08)%	(7.68)%	6.19%	7.94%	19.44% Total non-current liabilities ($000s)	$3,880	$4,450	$24,441	$24,913	$33,208	$31,818	$22,404	$14,858	$13,403	$3,749 EBIT ($000s)	($32,840)	($7,397)	($15,805)	($14,857)	$435	$1,622	$441	$2,470	$2,325	$2,257 Growth	-	-	-	-	(73.18%)	267.80%	(82.15%)	6.24%	3.01%	- EBIT margin	(99.07)%	(22.87)%	(70.66)%	(58.79)%	1.93%	7.77%	2.53%	13.46%	15.03%	19.44% TOTAL LIABILITIES ($000s)	$13,427	$19,998	$34,922	$31,873	$41,421	$40,213	$28,507	$20,164	$22,214	$5,581 Growth	(32.86%)	(42.74%)	9.57%	(23.05%)	3.00%	41.06%	41.38%	(9.23%)	298.03%	- Net profit margin	(123.66)%	(17.35)%	(55.47)%	(49.72)%	1.68%	4.97%	1.39%	9.92%	10.14%	13.17% NET ASSETS ($000s)	$45,734	$81,315	$57,298	$68,302	$43,338	$44,588	$21,041	$21,600	$19,025	$17,407 Equity	 	 	 	 	-	-	-	-	-	- Equity attributable to equity holders of the parent	 	 	 	 	-	-	-	-	-	-"
